Insider · CIK 0001459154

Wahlstrom Mats

Reports to the SEC for 3 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001459154

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	CHRSCoherus Oncology, Inc.A Award	Director	AAward	+30K sh	—	—	30,000
2026-06-05	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2026-05-15	TLSITriSalus Life Sciences, Inc.P Purchase	Director	PPurchase	+60K sh	$2.53	+$152K	147,555
2026-05-14	TLSITriSalus Life Sciences, Inc.A Award	Director	AAward	+37.6K sh	—	—	53,329
2026-05-14	TLSITriSalus Life Sciences, Inc.A Award	Director	AAward	+34.2K sh	—	—	87,555
2026-05-14	TLSITriSalus Life Sciences, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+75.2K sh	—	—	276,149
2025-06-12	TLSITriSalus Life Sciences, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	200,945
2025-06-12	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+112K sh	—	—	112,000
2025-05-23	CHRSCoherus Oncology, Inc.S Sale	Director	SSale	−100K sh	$0.74	−$73.9K	0
2025-02-10	TLSITriSalus Life Sciences, Inc. · Series A Convertible Preferred StockJ Other	Director	JOther	+44.8K sh	—	—	94,750
2024-12-17	TLSITriSalus Life Sciences, Inc.A Award	Director	AAward	+25.2K sh	$3.97	+$100K	40,915
2024-11-22	TLSITriSalus Life Sciences, Inc.P Purchase	Director	PPurchase	+5,000 sh	$4.55	+$22.8K	15,727
2024-11-21	TLSITriSalus Life Sciences, Inc.P Purchase	Director	PPurchase	+8,687 sh	$4.44	+$38.6K	10,727
2024-11-20	TLSITriSalus Life Sciences, Inc.P Purchase	Director	PPurchase	+2,040 sh	$4.16	+$8,486.4	2,040
2024-08-13	TLSITriSalus Life Sciences, Inc. · Director stock option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-06-03	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+112K sh	—	—	112,000
2024-02-09	CHRSCoherus Oncology, Inc.G Gift	Director	GGift	−100K sh	—	—	0
2024-02-09	CHRSCoherus Oncology, Inc.G Gift	Director	GGift	+100K sh	—	—	99,988
2024-02-01	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$1.67	+$25K	54,997
2024-02-01	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+45K sh	$1.67	+$75K	99,988
2024-02-01	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2024-02-01	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−45K sh	—	—	0
2023-08-10	TLSITriSalus Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-06-07	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38.3K sh	—	—	38,250
2022-02-28	CHRSCoherus Oncology, Inc.A Award	Director	AAward	+30K sh	$2.08	+$62.5K	40,000
2022-02-28	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	—	—	0
2022-02-25	CHRSCoherus Oncology, Inc.A Award	Director	AAward	+10K sh	$11.64	+$116K	10,006
2022-01-07	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2022-01-07	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2021-01-11	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-17	CHRSCoherus Oncology, Inc.S Sale	Director	SSale	−200K sh	$17.15	−$3.43M	0
2020-03-03	CHRSCoherus Oncology, Inc.S Sale	Director	SSale	−114K sh	$20.09	−$2.29M	204,222
2020-03-03	CHRSCoherus Oncology, Inc.S Sale	Director	SSale	−4,222 sh	$20.89	−$88.2K	200,000
2020-01-10	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-05-31	CHRSCoherus Oncology, Inc.J Other	Director	JOther	−179K sh	—	—	0
2019-05-31	CHRSCoherus Oncology, Inc.J Other	Director	JOther	+98.2K sh	—	—	318,066
2019-01-11	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-02-01	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-05-17	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-05-09	CHRSCoherus Oncology, Inc.J Other	Director	JOther	−200K sh	—	—	178,528
2017-05-09	CHRSCoherus Oncology, Inc.J Other	Director	JOther	+110K sh	—	—	219,914
2017-02-22	CHRSCoherus Oncology, Inc.J Other	Director	JOther	−200K sh	—	—	378,528
2017-02-22	CHRSCoherus Oncology, Inc.J Other	Director	JOther	+110K sh	—	—	109,957
2016-12-08	CHRSCoherus Oncology, Inc.S Sale	Director	SSale	−46.2K sh	$27.52	−$1.27M	0
2016-12-07	CHRSCoherus Oncology, Inc.S Sale	Director	SSale	−7,393 sh	$27.50	−$203K	46,190
2016-05-24	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-02-29	CHRSCoherus Oncology, Inc. · 8.2% Senior Convertible Notes due 2022P Purchase	Director	PPurchase	+1M sh	$22.35	+$22.4M	1,000,000
2016-02-29	CHRSCoherus Oncology, Inc. · 8.2% Senior Convertible Notes due 2022P Purchase	Director	PPurchase	—	$22.35	—	—
2015-08-18	CHRSCoherus Oncology, Inc.S Sale	Director	SSale	−6,372 sh	$33.50	−$213K	578,528
2015-08-18	CHRSCoherus Oncology, Inc.S Sale	Director	SSale	−6,373 sh	$33.50	−$214K	578,527

Recent filings

Accepted (ET)
Jun 94
Wahlstrom Mats0001610717-26-000201
SEC(opens sec.gov)
May 184
Wahlstrom Mats0001628280-26-035996
SEC(opens sec.gov)
May 154
Wahlstrom Mats0001628280-26-035667
SEC(opens sec.gov)
Jun 274
Wahlstrom Mats0001826667-25-000079
SEC(opens sec.gov)
Jun 134
Wahlstrom Mats0001610717-25-000227
SEC(opens sec.gov)
May 284
Wahlstrom Mats0001610717-25-000145
SEC(opens sec.gov)
Feb 114
Wahlstrom Mats0001415889-25-003621
SEC(opens sec.gov)
Dec 194
Wahlstrom Mats0001415889-24-029907
SEC(opens sec.gov)
Nov 254
Wahlstrom Mats0001415889-24-027656
SEC(opens sec.gov)
Nov 224
Wahlstrom Mats0001415889-24-027587
SEC(opens sec.gov)
Aug 214
Wahlstrom Mats0001415889-24-021962
SEC(opens sec.gov)
Jun 54
Wahlstrom Mats0001610717-24-000290
SEC(opens sec.gov)
Feb 154
Wahlstrom Mats0001610717-24-000060
SEC(opens sec.gov)
Feb 54
Wahlstrom Mats0001610717-24-000044
SEC(opens sec.gov)

Companies

Address

C/O COHERUS ONCOLOGY, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600

REDWOOD CITY, CA, 94065